Results 21 to 30 of about 1,973 (199)

It is all alopecia areata: It is time to abandon the terms alopecia totalis and alopecia universalis [PDF]

open access: yesJournal of the American Academy of Dermatology, 2022
Brittany Craiglow   +2 more
exaly   +3 more sources

Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study. [PDF]

open access: yesSkin Appendage Disord, 2021
Background/Aim: Alopecia areata (AA) is a common autoimmune hair disorder which is characterized by noncicatricial hair loss. AA commonly presents with localized patches on the scalp and face but may affect any hair-bearing region of the body leading to ...
Uzuncakmak TK   +3 more
europepmc   +2 more sources

Alopecia totalis successfully treated with modified platelet-rich plasma therapy in a patient recalcitrant to traditional treatment modalities

open access: yesClinical Dermatology Review, 2021
Alopecia areata (AA) is an autoimmune, nonscarring, inflammatory disorder of the scalp and/or body resulting in hair loss. Extensive AA such as alopecia totalis is increasingly unresponsive to conventional treatment modalities.
Sumit Gupta   +2 more
doaj   +1 more source

Selected clinical and laboratory parameters in patients with localized alopecia areata and patients with alopecia totalis / universalis. [PDF]

open access: yes, 2022
Selected clinical and laboratory parameters in patients with localized alopecia areata and patients with alopecia totalis / universalis.
Adriana Rakowska (8148795)   +7 more
core   +1 more source

Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report

open access: yesDermatology Reports, 2021
Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis, and alopecia totalis after dupilumab ...
Lama Alotaibi   +3 more
doaj   +1 more source

Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj   +1 more source

Supplemental Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta-analysis" [PDF]

open access: yes, 2019
Supplemental Table 1 and Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta ...
Silverberg, J (via Mendeley Data)
core   +3 more sources

Nail lichen planus in a patient with alopecia totalis [PDF]

open access: yes, 2015
A 67-year-old man with a three-year history of non-scarring alopecia that progressed to alopecia totalis despite intralesional glucocorticoid injections is presented.
Hale, Christopher S   +6 more
core   +1 more source

Drug-induced alopecia areata [PDF]

open access: yes, 2023
Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring alopecia. While most cases present as discrete patches of alopecia, some patients may develop total scalp hair loss (alopecia totalis) or total body hair loss (alopecia ...
Ezemma, O (via Mendeley Data)
core   +5 more sources

Home - About - Disclaimer - Privacy